Regarding anti-cytokine agents for the treatment of epilepsy, the efficacy of using anti-IL-1 and anti-IL-6 to control seizures in drug-resistant epilepsy and refractory status epilepticus has been reviewed [22]. This evidence concerns the gene IL1B and status epilepticus.